From Site to Submission: A Practical Guide to ICH-GCP E6(R3) Compliance
Decoding the updated ICH-GCP E6(R3) guidelines and what they mean for sponsors, CROs, and investigators in 2024 and beyond.
Insights & Articles
Field notes, research breakdowns, and career guidance from working pharmacovigilance scientists, clinical researchers, HEOR analysts, and medical writers.
Pharmacovigilance
How artificial intelligence and RWE are reshaping adverse event reporting, signal detection, and benefit-risk assessment across the pharmaceutical industry.
Dr. Aanya Sharma
November 18, 2024 · 9 min read
Latest articles
Decoding the updated ICH-GCP E6(R3) guidelines and what they mean for sponsors, CROs, and investigators in 2024 and beyond.
Best practices for designing RWE studies, choosing fit-for-purpose data sources, and presenting findings to HTA bodies.
A working framework for producing ICH-E3 compliant CSRs that move efficiently through regulatory and scientific review.
Why frontline health workers are the most powerful lever in India's fight against type 2 diabetes — and how to train them well.
How doctors, pharmacists, and public health professionals are building startups that solve problems they see every day.
Exploring the opportunities and the methodological rigor required to mine social listening data for safety signals.
Stay informed
One curated email per week: a new long-read, the week's most important regulatory and industry updates, and one open role worth applying to.
No spam. Unsubscribe with one click.